Wolverine Trading, LLC Alaunos Therapeutics, Inc. Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

22 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 23, 2023	BUY	$0.43 - $0.65 $4,687 - $7,085	10,900 Added 68.13%	26,900 $13,000
Q1 2023 May 15, 2023	BUY	$0.46 - $0.81 $7,360 - $12,960	16,000 New	16,000 $11,000
Q3 2022 Nov 14, 2022	BUY	$1.04 - $322.5 $46,488 - $14.4 Million	44,700 Added 266.07%	61,500 $122,000
Q2 2022 Aug 15, 2022	BUY	$0.41 - $1.24 $2,173 - $6,572	5,300 Added 46.09%	16,800 $21,000
Q1 2022 May 16, 2022	SELL	$0.62 - $1.17 $1,240 - $2,340	-2,000 Reduced 14.81%	11,500 $8,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.89 $14,715 - $25,515	13,500 New	13,500 $15,000
Q3 2021 Nov 12, 2021	SELL	$1.44 - $2.73 $24,048 - $45,591	-16,700 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$2.63 - $3.67 $5,786 - $8,074	-2,200 Reduced 11.64%	16,700 $45,000
Q1 2021 May 14, 2021	SELL	$2.82 - $5.6 $25,380 - $50,400	-9,000 Reduced 32.26%	18,900 $64,000
Q4 2020 Feb 12, 2021	SELL	$2.09 - $3.09 $4,807 - $7,107	-2,300 Reduced 7.62%	27,900 $74,000
Q3 2020 Nov 13, 2020	SELL	$2.39 - $3.43 $19,598 - $28,126	-8,200 Reduced 21.35%	30,200 $78,000
Q2 2020 Aug 13, 2020	SELL	$2.2 - $3.71 $58,960 - $99,428	-26,800 Reduced 41.1%	38,400 $123,000
Q1 2020 May 11, 2020	SELL	$1.9 - $4.98 $38,570 - $101,094	-20,300 Reduced 23.74%	65,200 $166,000
Q4 2019 Feb 12, 2020	SELL	$3.95 - $5.35 $14,220 - $19,260	-3,600 Reduced 4.04%	85,500 $410,000
Q3 2019 Nov 14, 2019	SELL	$4.13 - $6.94 $41,713 - $70,094	-10,100 Reduced 10.18%	89,100 $376,000
Q2 2019 Aug 20, 2019	BUY	$3.98 - $6.2 $93,530 - $145,700	23,500 Added 31.04%	99,200 $578,000
Q1 2019 May 15, 2019	SELL	$2.0 - $4.4 $128,600 - $282,920	-64,300 Reduced 45.93%	75,700 $291,000
Q4 2018 Feb 14, 2019	BUY	$1.61 - $3.62 $225,400 - $506,800	140,000 New	140,000 $232,000
Q3 2018 Nov 14, 2018	SELL	$2.26 - $3.27 $263,968 - $381,936	-116,800 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.46 - $5.14 $75,774 - $112,566	21,900 Added 23.08%	116,800 $458,000
Q4 2017 Feb 14, 2018	BUY	$4.0 - $6.54 $79,200 - $129,492	19,800 Added 26.36%	94,900 $393,000
Q3 2017 Nov 15, 2017	BUY	$4.99 - $6.57 $374,749 - $493,407	75,100	75,100 $461,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $517M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account